Home » Topics » BioWorld Science

BioWorld Science
RSS

Life Molecular Imaging opens enrollment for phase II trial of next-generation tau PET tracer PI-2620

Sep. 17, 2019

Neuronascent studies NNI-362 in healthy aged volunteers in first-in-human trial

Sep. 17, 2019

Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint

Sep. 17, 2019

DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease

Sep. 17, 2019

Acceleron ends development of ACE-083 for facioscapulohumeral muscular dystrophy

Sep. 17, 2019

CARB-X to fund Procarta's development of new class of antibiotics targeting ESKAPE pathogens

Sep. 17, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Boehringer Ingelheim synthesizes new EGFR mutant inhibitors

Sep. 17, 2019

Newave Pharmaceutical identifies WEE1hu inhibitors

Sep. 17, 2019

DE Shaw Research and Relay Therapeutics describe new PTP-1D inhibitors

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...